Cases 101 - 110 of 917
KRUG et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00194
Plaintiff:
Elizabeth Krug and Kevin Krug
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., JOHN DOE and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
QUEZADA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv00151
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
INSOKA QUEZADA
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
JACKSON v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv00154
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
KERRY JACKSON
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MASTBERGEN v. HETERO DRUGS, LTD. et al
as 1:2022cv00038
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
ESTATE OF NANCY MASTBERGEN
Defendant:
HETERO DRUGS, LTD., HETERO LABS, LTD., MYLAN LABORATORIES LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORSHAM v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00002
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CATHERINE WORSHAM
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MCFARLAND v. MYLAN LABORATORIES LTD. et al
as 1:2021cv20783
Plaintiff:
AMANDA MCFARLAND
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BOURGES v. AUROBINDO PHARMA, LTD. et al
as 1:2021cv20769
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
ALVA BOURGES
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SCAVONE et al v. AUROBINDO PHARMA, LTD. et al
as 1:2021cv20692
Plaintiff:
ANTHONY SCAVONE and ELAINE SCAVONE
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
WILSON v. AUROBINDO PHARMA, LTD. et al
as 1:2021cv20624
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
MELODIE WILSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
